Patents Assigned to AVENTI INC.
  • Pharmaceutical composition for preventing or treating muscular weakness-related diseases comprising alverine, 4-hydroxy alverine, derivative thereof, or pharmaceutically acceptable salt thereof
    Patent number: 12778906
    Abstract: A pharmaceutical or food composition including alverine, 4-hydroxy alverine, a derivative thereof, or a salt thereof and their uses are disclosed. The composition is useful for preventing, alleviating, or treating muscular weakness-related diseases. When myoblasts are treated with the alverine, 4-hydroxy alverine, derivative thereof, or salt thereof, differentiation into myotubes is promoted. Therefore, the alverine, 4-hydroxy alverine, derivative thereof, or salt thereof can be effectively used in the promotion of differentiation of myoblasts and the prevention, alleviation, or treatment of muscular weakness-related diseases.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: November 3, 2026
    Assignee: AVENTI INC.
    Inventors: Ki-Sun Kwon, Younglang Lee, Jong Hyun Yoon, Seung-Min Lee, Chang Hoon Jeon, Tai Hwan Ha, Do Yeun Jeong
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20230149326
    Abstract: A pharmaceutical or food composition including alverine, 4-hydroxy alverine, a derivative thereof, or a salt thereof and their uses are disclosed. The composition is useful for preventing, alleviating, or treating muscular weakness-related diseases. When myoblasts are treated with the alverine, 4-hydroxy alverine, derivative thereof, or salt thereof, differentiation into myotubes is promoted. Therefore, the alverine, 4-hydroxy alverine, derivative thereof, or salt thereof can be effectively used in the promotion of differentiation of myoblasts and the prevention, alleviation, or treatment of muscular weakness-related diseases.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 18, 2023
    Applicant: AVENTI INC.
    Inventors: Ki-Sun KWON, Younglang LEE, Jong Hyun YOON, Seung-Min LEE, Chang Hoon JEON, Tai Hwan HA, Do Yeun JEONG